NWSA vs XOMAP · rev $9.03B vs P/E 25, rev $28.5M
NWSA (NWSA) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
NWSA (NWSA) common stock.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
NWSA currently screens at market cap $0. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the NWSA and XOMAP stock pages for the full models.
Not investment advice.